Literature DB >> 30404030

Synthesis, characterization and biomedical applications of a novel Schiff base on methyl acrylate-functionalized chitosan bearing p-nitrobenzaldehyde groups.

El-Refaie Kenawy1, Sameh S Ali2, Marwa Al-Etewy1, Jianzhong Sun3, Jian Wu4, Nessma El-Zawawy5.   

Abstract

Amino-functionalization has gained significant attention in the chemical modification of carbohydrate polymers due to their potential biomedical applications. Here, the preparation of innovative functionalized chitosan bearing amino-containing groups and equipped with p-nitrobenzaldehyde groups, resulting in an aminated chitosan bearing p-nitrobenzaldehyde (AmCs-pNBA) was described for the first time. The most important advantage of the chitosan functionalization was the success of its preparation at room temperature, avoiding the polymerization of methyl acrylate and instead it reacted entirely with chitosan. The resulting methyl acrylate chitosan was subsequently improved by the synthesized AmCs-pNBA Schiff base via the condensation of aldehyde groups with aminated chitosan. The structural characteristics of AmCs-pNBA were examined by FT-IR, XRD, TGA, SEM, and elemental analysis techniques. The antimicrobial, antioxidant, and anti-biofilm activities of AmCs-pNBA were assessed in vitro. The results revealed that this newly synthesized chitosan derivative displayed significant superior antibacterial, antioxidant, and anti-biofilm activities over the original chitosan. Besides, cytotoxicity and hemolytic analysis of the AmCs-pNBA were also evaluated. Results indicated that AmCs-pNBA support cell viability and proliferation without obvious hemolysis. These results show the potential of synthesizing the novel biomaterial candidate, AmCs-pNBA, with improved antibacterial, anti-biofilm, and antioxidant properties that may open a new perspective in biomedical applications.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chitosan; Chitosan Schiff base; Pharmaceutical applications

Mesh:

Substances:

Year:  2018        PMID: 30404030     DOI: 10.1016/j.ijbiomac.2018.11.005

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  6 in total

Review 1.  Potential applications of hydrophobically modified inulin as an active ingredient in functional foods and drugs - A review.

Authors:  Muhammad Usman; Chengnan Zhang; Prasanna Jagannath Patil; Arshad Mehmood; Xiuting Li; Muhammad Bilal; Junaid Haider; Shabbir Ahmad
Journal:  Carbohydr Polym       Date:  2020-10-06       Impact factor: 9.381

2.  Syzygium aromaticum L.: Traditional herbal medicine against cagA and vacA toxin genes-producing drug resistant Helicobacter pylori.

Authors:  Wagih A El-Shouny; Sameh S Ali; Hegazy M Hegazy; Manar K Abd Elnabi; Asmaa Ali; Jianzhong Sun
Journal:  J Tradit Complement Med       Date:  2019-05-15

3.  Ecofriendly biodegradation of Reactive Black 5 by newly isolated Sterigmatomyces halophilus SSA1575, valued for textile azo dye wastewater processing and detoxification.

Authors:  Rania Al-Tohamy; Jianzhong Sun; Mervat F Fareed; El-Refaie Kenawy; Sameh S Ali
Journal:  Sci Rep       Date:  2020-07-23       Impact factor: 4.379

4.  Performance of a Newly Isolated Salt-Tolerant Yeast Strain Sterigmatomyces halophilus SSA-1575 for Azo Dye Decolorization and Detoxification.

Authors:  Rania Al-Tohamy; El-Refaie Kenawy; Jianzhong Sun; Sameh Samir Ali
Journal:  Front Microbiol       Date:  2020-06-11       Impact factor: 5.640

5.  Antimicrobial efficacy of Egyptian Eremina desertorum and Helix aspersa snail mucus with a novel approach to their anti-inflammatory and wound healing potencies.

Authors:  Nessma A El-Zawawy; Mahy M Mona
Journal:  Sci Rep       Date:  2021-12-21       Impact factor: 4.379

6.  Antiulcerogenic and Antibacterial Effects of Chitosan Derivatives on Experimental Gastric Ulcers in Rats.

Authors:  Leudimar Aires Pereira; Luizângela da Silva Reis; Anderson Nogueira Mendes; Hélio de Barros Fernandes; Daniel Dias Rufino Arcanjo; Adalberto Fortes Rodrigues Júnior; Janete Martins Sousa; Humberto Medeiros Barreto; Jailson de Araújo Santos; Josy Anteveli Osajima; Edson C Silva Filho
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-16       Impact factor: 2.650

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.